SOBEL ALAN D. reported 1 transaction at CYTOSORBENTS CORP
Review the transaction codes below to understand the nature of each event.
Filed: 1/22/2025ACC: 0001104659-25-005354
+43.90K
Net shares
Net buyer
$21.9K
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
65.85K acquired · 21.95K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.95K
Price / share
$1.00
Trade value
$21.95K
% of position
21.5%
1/17/2025
101.86K→123.81K
Total
Net shares
+21.95K
Net value
$21.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/17/2025 | X · X | +21.95K | $1.00 | $21.95K | 21.5% | 101.86K | 123.81K |
| Total | +21.95K | $21.95K | ||||||
Derivative Transactions3
Subscription Rights (right to buy)
Direct
Converts to
Common Stock
21.95K shares
Shares
−21.95K
Strike price
1.00
Held after
0.00
Exercisable
—
1/17/2025
Series A Right Warrants
Direct
Converts to
Common Stock
21.95K shares
Shares
+21.95K
Strike price
Held after
21.95K
Exercisable
—
1/17/2025
Series B Right Warrants
Direct
Converts to
Common Stock
21.95K shares
Shares
+21.95K
Strike price
Held after
21.95K
Exercisable
—
1/17/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Subscription Rights (right to buy) Direct | Common Stock21.95K shares | 1/17/2025 | X · X | −21.95K | 1.00 | — | 0.00 |
| Series A Right Warrants Direct | Common Stock21.95K shares | 1/17/2025 | J · J | +21.95K | — | 21.95K | |
| Series B Right Warrants Direct | Common Stock21.95K shares | 1/17/2025 | J · J | +21.95K | — | 21.95K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2K
Total
2K indirect2K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2K | Indirect |
| Total | 2K | 2K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported